Biological predictors of response to antidepressants

Trial Profile

Biological predictors of response to antidepressants

Phase of Trial: Phase II

Latest Information Update: 16 Jun 2017

At a glance

  • Drugs Escitalopram (Primary) ; Desipramine
  • Indications Major depressive disorder
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 04 Apr 2012 Additional lead trial centre (New York State Psychiatric Institute) added as reported by
    • 04 Apr 2012 Planned end date changed from 1 Sep 2011 to 1 May 2012 as reported by
    • 22 Oct 2008 Planned end date is 1 Sep 2011.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top